Skip to main content
Publication date
2017 Mar
Authors
van Vollenhoven, R Voskuyl, A Bertsias, G Aranow, C Aringer, M Arnaud, L Askanase, A Balazova, P Bonfa, E Bootsma, H Boumpas, D Bruce, I Cervera, R Clarke, A Coney, C Costedoat-Chalumeau, N Czirjak, L Derksen, R Doria, A Dorner, T Fischer-Betz, R Fritsch-Stork, R Gordon, C Graninger, W Gyori, N Houssiau, F Isenberg, D Jacobsen, S Jayne, D Kuhn, A Le Guern, V Lerstrom, K Levy, R Machado-Ribeiro, F Mariette, X Missaykeh, J Morand, E Mosca, M Inanc, M Navarra, S Neumann, I Olesinska, M Petri, M Rahman, A Rekvig, OP Rovensky, J Shoenfeld, Y Smolen, J Tincani, A Urowitz, M van Leeuw, B Vasconcelos, C Voss, A Werth, VP Zakharova, H Zoma, A Schneider, M Ward, M
Author KI Usernames
van Vollenhoven, R|ronvan
Pubmed ID
27884822
Journal
Annals of the rheumatic diseases
Doctype
Article
KI Connection
Hög
Mesh SV
Antimalariamedel Antinukleära antikroppar Binjurebarkshormoner DNA Immunhämmande medel Komplementproteiner Konsensus Människa Remissionsinduktion Sjukdomsgradsmått Skov Systemisk lupus erythematosus Underhållande kemoterapi
Mesh EN
Adrenal Cortex Hormones Antibodies, Antinuclear Antimalarials Complement System Proteins Consensus DNA Immunosuppressive Agents Lupus Erythematosus, Systemic Maintenance Chemotherapy Remission Induction Severity of Illness Index Symptom Flare Up
First date
2017-04-02T10:20:14.915Z